Global Hepatocyte Growth Factor Market Growth 2019-2024
- ID:PD040704
- January 2019
- LPI (LP Information)
The Global Hepatocyte Growth Factor Market Research Report available with DecisionDatabases.com explores the market statistics between 2019 to 2024. The historic data of Hepatocyte Growth Factor market size, market share, revenue, consumption, sales has been gathered, analysed and compiled in this report assuring high quality and precision. The future trends are explored under the guidance of industry experts and analysts. The forecast trends and Hepatocyte Growth Factor industry outlook will assist opportunists with ideal information and data to take an informed decision.
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.
The application of hepatocyte growth factor includes oncology, cardiovascular, central nervous system, hematological disorders and others, and the proportion of R&D Investment for oncology in 2017 is about 36%, and the proportion is in decreasing trend from 2012 to 2016.
Asia Pacific will be the largest market, which will occupy nearly 62% market share in 2030. Following Asia Pacific, North America will be the second largest market with the consumption market share of 25% in 2030.
According to this study, over the next five years the Hepatocyte Growth Factor market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hepatocyte Growth Factor business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatocyte Growth Factor market by product type, application, key manufacturers and key regions and countries.
This study considers the Hepatocyte Growth Factor value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
- Type I
- Type II
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
- Oncology
- Cardiovascular
- Central Nervous System
- Hematological Disorders
- Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
- ViroMed
- AnGes MG
- M3 Biotechnology
- AVEO Pharmaceuticals
- Molecular Partners
- Yooyoung Pharm
- F-star
- Galaxy Biotech
- Kringle Pharma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
- To study and analyze the global Hepatocyte Growth Factor consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
- To understand the structure of Hepatocyte Growth Factor market by identifying its various subsegments.
- Focuses on the key global Hepatocyte Growth Factor manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Hepatocyte Growth Factor with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Hepatocyte Growth Factor submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hepatocyte Growth Factor Consumption 2014-2024
2.1.2 Hepatocyte Growth Factor Consumption CAGR by Region
2.2 Hepatocyte Growth Factor Segment by Type
2.2.1 Type I
2.2.2 Type II
2.3 Hepatocyte Growth Factor Consumption by Type
2.3.1 Global Hepatocyte Growth Factor Consumption Market Share by Type (2014-2019)
2.3.2 Global Hepatocyte Growth Factor Revenue and Market Share by Type (2014-2019)
2.3.3 Global Hepatocyte Growth Factor Sale Price by Type (2014-2019)
2.4 Hepatocyte Growth Factor Segment by Application
2.4.1 Oncology
2.4.2 Cardiovascular
2.4.3 Central Nervous System
2.4.4 Hematological Disorders
2.4.5 Others
2.5 Hepatocyte Growth Factor Consumption by Application
2.5.1 Global Hepatocyte Growth Factor Consumption Market Share by Application (2014-2019)
2.5.2 Global Hepatocyte Growth Factor Value and Market Share by Application (2014-2019)
2.5.3 Global Hepatocyte Growth Factor Sale Price by Application (2014-2019)
3 Global Hepatocyte Growth Factor by Players
3.1 Global Hepatocyte Growth Factor Sales Market Share by Players
3.1.1 Global Hepatocyte Growth Factor Sales by Players (2017-2019)
3.1.2 Global Hepatocyte Growth Factor Sales Market Share by Players (2017-2019)
3.2 Global Hepatocyte Growth Factor Revenue Market Share by Players
3.2.1 Global Hepatocyte Growth Factor Revenue by Players (2017-2019)
3.2.2 Global Hepatocyte Growth Factor Revenue Market Share by Players (2017-2019)
3.3 Global Hepatocyte Growth Factor Sale Price by Players
3.4 Global Hepatocyte Growth Factor Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Hepatocyte Growth Factor Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Hepatocyte Growth Factor Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Hepatocyte Growth Factor by Regions
4.1 Hepatocyte Growth Factor by Regions
4.1.1 Global Hepatocyte Growth Factor Consumption by Regions
4.1.2 Global Hepatocyte Growth Factor Value by Regions
4.2 Americas Hepatocyte Growth Factor Consumption Growth
4.3 APAC Hepatocyte Growth Factor Consumption Growth
4.4 Europe Hepatocyte Growth Factor Consumption Growth
4.5 Middle East & Africa Hepatocyte Growth Factor Consumption Growth
5 Americas
5.1 Americas Hepatocyte Growth Factor Consumption by Countries
5.1.1 Americas Hepatocyte Growth Factor Consumption by Countries (2014-2019)
5.1.2 Americas Hepatocyte Growth Factor Value by Countries (2014-2019)
5.2 Americas Hepatocyte Growth Factor Consumption by Type
5.3 Americas Hepatocyte Growth Factor Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Hepatocyte Growth Factor Consumption by Countries
6.1.1 APAC Hepatocyte Growth Factor Consumption by Countries (2014-2019)
6.1.2 APAC Hepatocyte Growth Factor Value by Countries (2014-2019)
6.2 APAC Hepatocyte Growth Factor Consumption by Type
6.3 APAC Hepatocyte Growth Factor Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Hepatocyte Growth Factor by Countries
7.1.1 Europe Hepatocyte Growth Factor Consumption by Countries (2014-2019)
7.1.2 Europe Hepatocyte Growth Factor Value by Countries (2014-2019)
7.2 Europe Hepatocyte Growth Factor Consumption by Type
7.3 Europe Hepatocyte Growth Factor Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Hepatocyte Growth Factor by Countries
8.1.1 Middle East & Africa Hepatocyte Growth Factor Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Hepatocyte Growth Factor Value by Countries (2014-2019)
8.2 Middle East & Africa Hepatocyte Growth Factor Consumption by Type
8.3 Middle East & Africa Hepatocyte Growth Factor Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Hepatocyte Growth Factor Distributors
10.3 Hepatocyte Growth Factor Customer
11 Global Hepatocyte Growth Factor Market Forecast
11.1 Global Hepatocyte Growth Factor Consumption Forecast (2019-2024)
11.2 Global Hepatocyte Growth Factor Forecast by Regions
11.2.1 Global Hepatocyte Growth Factor Forecast by Regions (2019-2024)
11.2.2 Global Hepatocyte Growth Factor Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Hepatocyte Growth Factor Forecast by Type
11.8 Global Hepatocyte Growth Factor Forecast by Application
12 Key Players Analysis
12.1 ViroMed
12.1.1 Company Details
12.1.2 Hepatocyte Growth Factor Product Offered
12.1.3 ViroMed Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 ViroMed News
12.2 AnGes MG
12.2.1 Company Details
12.2.2 Hepatocyte Growth Factor Product Offered
12.2.3 AnGes MG Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 AnGes MG News
12.3 M3 Biotechnology
12.3.1 Company Details
12.3.2 Hepatocyte Growth Factor Product Offered
12.3.3 M3 Biotechnology Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 M3 Biotechnology News
12.4 AVEO Pharmaceuticals
12.4.1 Company Details
12.4.2 Hepatocyte Growth Factor Product Offered
12.4.3 AVEO Pharmaceuticals Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 AVEO Pharmaceuticals News
12.5 Molecular Partners
12.5.1 Company Details
12.5.2 Hepatocyte Growth Factor Product Offered
12.5.3 Molecular Partners Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Molecular Partners News
12.6 Yooyoung Pharm
12.6.1 Company Details
12.6.2 Hepatocyte Growth Factor Product Offered
12.6.3 Yooyoung Pharm Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Yooyoung Pharm News
12.7 F-star
12.7.1 Company Details
12.7.2 Hepatocyte Growth Factor Product Offered
12.7.3 F-star Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 F-star News
12.8 Galaxy Biotech
12.8.1 Company Details
12.8.2 Hepatocyte Growth Factor Product Offered
12.8.3 Galaxy Biotech Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Galaxy Biotech News
12.9 Kringle Pharma
12.9.1 Company Details
12.9.2 Hepatocyte Growth Factor Product Offered
12.9.3 Kringle Pharma Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Kringle Pharma News
13 Research Findings and Conclusion
The Global Tigecycline Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost read more..
Global Caffeine Market Research Report 2017
The Global Caffeine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost structure, read more..
Global Rabies Vaccine Market Research Report 2017
The Global Rabies Vaccine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost read more..
United States Parkinsons Disease Drug Market Report 2018-2025
The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers, read more..
Global Radiopharmaceuticals Market Research Report 2019
The Global Radiopharmaceuticals market report is a recent research added by DecisionDatabases.com, offers critical insight into the Market dynamic. This read more..
Global Neurorehabilitation System Market Research Report
Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method read more..
Global Molecular Biology Kits And Reagents Market Research Report
The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in read more..
Global High Acuity Care Information Systems Market Research Report
The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus read more..
Global Regenerative Medicine Market Research Report
The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013. A number of factors such as increasing bone related read more..
Global Skin Cancer Diagnostics Market Research Report
Cancers of skin tissues are one of the major types of cancers in the world. In recent years, more than 40% of all cancers in the U.S. have been skin read more..